Lung cancer was the leading cause of cancer-related death in 2020. Nearly half of those patients diagnosed were found to be late-stage. There has been ongoing work to increase screening for lung cancer in at-risk patients with enhanced imaging. However, after identification of suspicious masses, there remains the task of diagnosing any cancerous lesions. Unfortunately, obtaining accurate biopsy results has been a challenge either due to inaccurate results from conventional bronchoscopy, or risk from alternative mechanisms of biopsy.

Read More